138 related articles for article (PubMed ID: 33936219)
21. Prognostic Significance of Lymphovascular Invasion Detected by D2-40 in Low-Risk Stage II Colon Cancer.
Prugmahachaikul A; Sanpavat A
Cureus; 2021 Nov; 13(11):e19825. PubMed ID: 34963842
[TBL] [Abstract][Full Text] [Related]
22. Peritumoral lymphatic vessel density and invasion detected with immunohistochemical marker D240 is strongly associated with distant metastasis in breast carcinoma.
Norhisham NF; Chong CY; Safuan S
BMC Clin Pathol; 2017; 17():2. PubMed ID: 28203117
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of lymphatic vessel invasion diagnosed by D2-40 in Chinese invasive breast cancers.
He KW; Sun JJ; Liu ZB; Zhuo PY; Ma QH; Liu ZY; Yu ZY
Medicine (Baltimore); 2017 Nov; 96(44):e8490. PubMed ID: 29095309
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of detecting lymphatic and blood vessel invasion in stage II colon cancer using markers D2-40 and CD34 in combination.
Lai JH; Zhou YJ; Bin D; Qiangchen ; Wang SY
Asian Pac J Cancer Prev; 2014; 15(3):1363-7. PubMed ID: 24606466
[TBL] [Abstract][Full Text] [Related]
25. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
Mohammed RA; Martin SG; Gill MS; Green AR; Paish EC; Ellis IO
Am J Surg Pathol; 2007 Dec; 31(12):1825-33. PubMed ID: 18043036
[TBL] [Abstract][Full Text] [Related]
26. Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study.
Van den Eynden GG; Van der Auwera I; Van Laere SJ; Colpaert CG; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
Br J Cancer; 2006 Jun; 94(11):1643-9. PubMed ID: 16670715
[TBL] [Abstract][Full Text] [Related]
27. Detection of D2-40 monoclonal antibody-labeled lymphatic vessel invasion in esophageal squamous cell carcinoma and its clinicopathologic significance.
Bai B; Ma W; Wang K; Ha S; Wang JB; Tan BX; Wang NN; Yang SS; Jia YB; Cheng YF
Cancer Biol Med; 2013 Jun; 10(2):81-5. PubMed ID: 23882422
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients.
Tezuka K; Onoda N; Takashima T; Takagaki K; Ishikawa T; Wakasa T; Wakasa K; Hirakawa K
Oncol Rep; 2007 May; 17(5):997-1003. PubMed ID: 17390035
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Methods to Identify Lymphatic and Blood Vessel Invasion and their Prognostic Value in Patients with Primary Operable Colorectal Cancer.
Van Wyk HC; Foulis AK; Roxburgh CS; Orange C; Horgan PG; McMillan DC
Anticancer Res; 2015 Dec; 35(12):6457-63. PubMed ID: 26637856
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer.
Gujam FJ; Going JJ; Mohammed ZM; Orange C; Edwards J; McMillan DC
BMC Cancer; 2014 Sep; 14():676. PubMed ID: 25234410
[TBL] [Abstract][Full Text] [Related]
31. Use of Immunostaining for the diagnosis of Lymphovascular invasion in superficial Barrett's esophageal adenocarcinoma.
Hosono I; Miyahara R; Furukawa K; Funasaka K; Sawada T; Maeda K; Yamamura T; Ishikawa T; Ohno E; Nakamura M; Kawashima H; Yokoi T; Tsukamoto T; Hirooka Y; Fujishiro M
BMC Gastroenterol; 2020 Jun; 20(1):175. PubMed ID: 32503448
[TBL] [Abstract][Full Text] [Related]
32. ERG Immunohistochemistry as an Endothelial Marker for Assessing Lymphovascular Invasion.
Kim S; Park HK; Jung HY; Lee SY; Min KW; Kim WY; Han HS; Kim WS; Hwang TS; Lim SD
Korean J Pathol; 2013 Aug; 47(4):355-64. PubMed ID: 24009631
[TBL] [Abstract][Full Text] [Related]
33. The aggressiveness of urothelial carcinoma depends to a large extent on lymphovascular invasion--the prognostic contribution of related molecular markers.
Afonso J; Santos LL; Amaro T; Lobo F; Longatto-Filho A
Histopathology; 2009 Nov; 55(5):514-24. PubMed ID: 19912357
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Implication of Lymphovascular Invasion Detected by Double Immunostaining for D2-40 and MITF1 in Primary Cutaneous Melanoma.
Feldmeyer L; Tetzlaff M; Fox P; Nagarajan P; Curry J; Ivan D; Torres Cabala CA; Prieto VG; Aung PP
Am J Dermatopathol; 2016 Jul; 38(7):484-91. PubMed ID: 26675354
[TBL] [Abstract][Full Text] [Related]
35. Multiple combinations of melanocytic and vascular endothelial markers enhance the detection rate of lymphovascular invasion in cutaneous melanoma.
Bayram A; Ozturk Sari S; Ozluk Y; Tas F; Buyukbabani N
J Cutan Pathol; 2021 Apr; 48(4):472-478. PubMed ID: 32935876
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas.
El-Gohary YM; Metwally G; Saad RS; Robinson MJ; Mesko T; Poppiti RJ
Am J Clin Pathol; 2008 Apr; 129(4):578-86. PubMed ID: 18343785
[TBL] [Abstract][Full Text] [Related]
37. The role of lymphatic and blood vessel invasion in predicting survival and methods of detection in patients with primary operable breast cancer.
Gujam FJ; Going JJ; Edwards J; Mohammed ZM; McMillan DC
Crit Rev Oncol Hematol; 2014 Feb; 89(2):231-41. PubMed ID: 24075309
[TBL] [Abstract][Full Text] [Related]
38. D2-40-positive lymphatic vessel invasion is not a poor prognostic factor in stage I lung adenocarcinoma.
Shimizu K; Funai K; Sugimura H; Sekihara K; Kawase A; Shiiya N
Pathol Int; 2013 Apr; 63(4):201-5. PubMed ID: 23692420
[TBL] [Abstract][Full Text] [Related]
39. Analysis of lymphatic and blood vessel invasion biomarkers in T1 esophagogastric adenocarcinomas for improved patient prognostication.
Perry C; Soomro I; Kaye P; Hardy E; Parsons SL; Ragunath K; Lobo DN; Martin SG; Madhusudan S
Dis Esophagus; 2015 Apr; 28(3):262-8. PubMed ID: 24612464
[TBL] [Abstract][Full Text] [Related]
40. Objective assessment of lymphatic and blood vascular invasion in lymph node-negative breast carcinoma: findings from a large case series with long-term follow-up.
Mohammed RA; Martin SG; Mahmmod AM; Macmillan RD; Green AR; Paish EC; Ellis IO
J Pathol; 2011 Feb; 223(3):358-65. PubMed ID: 21171081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
